StockData
Skinvisible, Inc. logo

Skinvisible, Inc. (SKVI) stock

SKVIOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.16+0.00 (+0.06%)

Close on Oct 19, 2026Market cap $843.54KP/E –Yield –

Skinvisible enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Skinvisible's enterprise value was $839.58K on Oct 19, 2026, against $2.71M a year earlier. Over the last 5 years it ranged from $273.38K to $3.77M, with a median of $841.80K.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$839.58K-32.6%
2025Dec 31, 2025$1.25M-24.4%
2024Dec 31, 2024$1.65M+334.1%
2023Dec 29, 2023$379.48K+14.5%
2022Dec 30, 2022$331.57K-68.1%
2021Dec 31, 2021$1.04M+267.4%
2020Dec 31, 2020$283.27K+12.1%
2019Dec 31, 2019$252.77K-96.3%
2018Dec 31, 2018$6.76M+33.1%
2017Dec 29, 2017$5.08M+173.4%
2016Dec 30, 2016$1.86M-45.1%
2015Dec 31, 2015$3.38M-30.3%
2014Dec 31, 2014$4.85M+200.3%
2013Dec 31, 2013$1.61M-54.9%
2012Dec 31, 2012$3.58M-34.2%
2011Dec 30, 2011$5.45M–

More Skinvisible figures

See a number that looks wrong?